29,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
15 °P sammeln
  • Broschiertes Buch

In an era in which medicine is no longer merely curative but truly preventive, genetic therapies are positioned as the boldest frontier of human knowledge. CRISPR: the tool capable of editing DNA with surgical precision, opens the possibility of correcting mutations before birth, offering hope to families affected by diseases such as sickle cell anemia, cystic fibrosis or muscular dystrophies. This book guides the reader through the scientific underpinnings of this revolution, presents real clinical cases, explores profound ethical challenges, and discusses the role that students and…mehr

Produktbeschreibung
In an era in which medicine is no longer merely curative but truly preventive, genetic therapies are positioned as the boldest frontier of human knowledge. CRISPR: the tool capable of editing DNA with surgical precision, opens the possibility of correcting mutations before birth, offering hope to families affected by diseases such as sickle cell anemia, cystic fibrosis or muscular dystrophies. This book guides the reader through the scientific underpinnings of this revolution, presents real clinical cases, explores profound ethical challenges, and discusses the role that students and physicians can play in this emerging field. With a critical and visionary eye, the book shows how these technologies are redefining what we mean by health, heredity, and the future. In the end, an inevitable question remains: if we can already change the history of a disease before we are born... are we ready to change the history of humanity?
Autorenporträt
Grace Angie Largaespada i Stacy Valdivia, studentki medycyny i chirurgii na Uniwersytecie Amerykäskim (UAM), specjalizuj¿ si¿ w badaniach biomedycznych i medycynie prewencyjnej.